Holen Sie sich die Stockscreener-App
6.53
1.36%
-0.09
Schlusskurs vom Vortag:
$6.62
Offen:
$6.57
24-Stunden-Volumen:
753.13K
Relative Volume:
1.89
Marktkapitalisierung:
$385.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-153.16M
KGV:
-1.7696
EPS:
-3.69
Netto-Cashflow:
$-134.48M
1W Leistung:
-6.58%
1M Leistung:
-10.18%
6M Leistung:
-28.08%
1J Leistung:
-62.94%
1-Tages-Spanne:
$6.37
$6.76
1-Wochen-Bereich:
$6.37
$7.09
52-Wochen-Spanne:
$6.37
$18.62
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Firmenname
Cullinan Therapeutics Inc
Sektor
Branche
Telefon
617-410-4650
Adresse
ONE MAIN STREET, CAMBRIDGE
Vergleichen Sie CGEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
6.53 | 382.21M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-06-11 | Fortgesetzt | Stifel | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-05-01 | Eingeleitet | Stifel | Buy |
| 2024-04-15 | Eingeleitet | William Blair | Outperform |
| 2024-02-15 | Eingeleitet | Wedbush | Outperform |
| 2023-06-15 | Eingeleitet | TD Cowen | Outperform |
| 2022-11-21 | Eingeleitet | BTIG Research | Buy |
| 2021-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-02-02 | Eingeleitet | Evercore ISI | Outperform |
| 2021-02-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-02-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-02-01 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cullinan Therapeutics Inc Aktie (CGEM) Neueste Nachrichten
Will Cullinan Therapeutics Inc. see short term momentumEarnings Summary Report & AI Driven Price Predictions - Newser
Will earnings trigger a reversal in Cullinan Therapeutics Inc.2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
Applying Elliott Wave Theory to Cullinan Therapeutics Inc.Market Rally & Risk Managed Investment Strategies - Newser
Ranking Cullinan Therapeutics Inc. among high performing stocks via toolsQuarterly Portfolio Summary & Expert Curated Trade Setup Alerts - Newser
Top chart patterns to watch in Cullinan Therapeutics Inc.July 2025 Spike Watch & Weekly Chart Analysis and Trade Guides - Newser
What institutional flow reveals about Cullinan Therapeutics Inc.Quarterly Market Review & Long-Term Growth Portfolio Plans - Newser
Trexquant Investment LP Takes Position in Cullinan Therapeutics, Inc. $CGEM - MarketBeat
Will Cullinan Therapeutics Inc. continue its uptrend2025 Technical Patterns & Risk Managed Investment Signals - Newser
What’s the recovery path for long term holders of Cullinan Therapeutics Inc.July 2025 Fed Impact & Advanced Technical Signal Analysis - Newser
Combining price and volume data for Cullinan Therapeutics Inc.Earnings Growth Report & High Accuracy Swing Trade Signals - Newser
Cullinan Therapeutics Inc. stock trend outlook and recovery pathMarket Movers & Fast Entry High Yield Tips - Newser
What candlestick patterns are forming on Cullinan Therapeutics Inc.Market Rally & Long-Term Growth Stock Strategies - Newser
What to do if you’re stuck in Cullinan Therapeutics Inc.Trade Volume Summary & Consistent Profit Alerts - Newser
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum - GlobeNewswire
Leading Biotech Cullinan Therapeutics to Share Targeted Therapy Pipeline at Stifel 2025 Immunology Forum - Stock Titan
Real time scanner hits for Cullinan Therapeutics Inc. explainedJuly 2025 Final Week & Expert Approved Trade Ideas - Newser
What MACD signals say about Cullinan Therapeutics Inc.Chart Signals & Community Trade Idea Sharing Platform - Newser
Analyzing drawdowns of Cullinan Therapeutics Inc. with statistical tools2025 Key Lessons & Long-Term Capital Growth Strategies - Newser
Published on: 2025-09-12 03:40:51 - Newser
Multi factor analysis applied to Cullinan Therapeutics Inc.July 2025 Trends & Risk Managed Investment Signals - Newser
Automated trading signals detected on Cullinan Therapeutics Inc.2025 Historical Comparison & Growth Oriented Trade Recommendations - Newser
Building trade automation scripts for Cullinan Therapeutics Inc.Trade Performance Summary & Consistent Income Trade Ideas - Newser
Chart overlay techniques for tracking Cullinan Therapeutics Inc.2025 Key Lessons & Detailed Earnings Play Alerts - Newser
Can trapped investors hope for a rebound in Cullinan Therapeutics Inc.2025 Top Decliners & Low Risk Growth Stock Ideas - Newser
Cullinan Therapeutics to Participate in Upcoming Investor Conferences - 富途牛牛
When is the best time to exit Cullinan Therapeutics Inc.July 2025 Outlook & Free Technical Pattern Based Buy Signals - Newser
Cullinan Therapeutics, Inc. $CGEM Shares Sold by Walleye Capital LLC - MarketBeat
Risk vs reward if holding onto Cullinan Therapeutics Inc.July 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Transcript : Cullinan Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 08 - MarketScreener
Statistical indicators supporting Cullinan Therapeutics Inc.’s strengthGlobal Markets & Consistent Profit Trading Strategies - Newser
Chart based analysis of Cullinan Therapeutics Inc. trendsPortfolio Return Report & Long-Term Growth Plans - Newser
What makes Watts Water Technologies, Inc. stock price move sharply - Newser
Measuring Cullinan Therapeutics Inc.’s beta against major indicesOptions Play & Precise Trade Entry Recommendations - Newser
Using RSI to spot recovery in Cullinan Therapeutics Inc.Weekly Loss Report & Verified Momentum Watchlists - Newser
Published on: 2025-09-09 23:45:11 - Newser
Will a bounce in Cullinan Therapeutics Inc. offer an exitJuly 2025 Action & Expert Curated Trade Setups - Newser
Analyzing net buyer seller activity in Cullinan Therapeutics Inc.Weekly Volume Report & Free AI Powered Buy and Sell Recommendations - Newser
Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):